Adventa Bhd
Adventa Bhd provides medical equipment, supplies, and distribution services within the healthcare sector, generating revenue primarily through the sale and distribution of medical products.
Business. Adventa Bhd (ADVE.KL) is a healthcare services and equipment company primarily engaged in the medical equipment, supplies, and distribution industry. The firm operates on a product-sale revenue model, focusing on the provision of medical devices and related consumables. Headquartered in Malaysia, the company is listed on the Bursa Malaysia stock exchange. Specific details regarding its operating segments and geographic revenue mix are not disclosed in the available data.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Adventa Bhd (ADVE.KL) is a healthcare services and equipment company primarily engaged in the medical equipment, supplies, and distribution industry. The firm operates on a product-sale revenue model, focusing on the provision of medical devices and related consumables. Headquartered in Malaysia, the company is listed on the Bursa Malaysia stock exchange. Specific details regarding its operating segments and geographic revenue mix are not disclosed in the available data.
Adventa Bhd maintains a strong liquidity position, with a current ratio of 5.6, indicating that it holds significantly more current assets than current liabilities. However, the company reported negative operating cash flow of MYR -6,198,000 and free cash flow of MYR -4,676,000, suggesting that it is currently spending more cash than it is generating from operations. The company's capital expenditure of MYR -5,300,000 reflects ongoing investment in long-term assets, but this is being funded by negative cash flows, which could raise concerns about long-term sustainability.
Profitability metrics for Adventa Bhd are modest, with a return on equity (ROE) of 0.33% and a return on assets (ROA) of 0.30%. These figures are below the typical thresholds for strong performance in the medical equipment and supplies industry, where higher returns are often expected due to the capital-intensive nature of the business. The company's operating income of MYR 498,000 and net income of MYR 304,000 suggest limited profitability, which may constrain its ability to reinvest in growth or reward shareholders.
The company's revenue is concentrated in a single business segment, as no segmental breakdown is provided in the available data. This lack of diversification could expose Adventa Bhd to higher operational risk if demand for medical equipment and supplies fluctuates. Geographically, the company operates primarily in Malaysia, as indicated by the MYR-based financials, and there is no evidence of significant international exposure.
Looking ahead, Adventa Bhd's growth trajectory appears uncertain. The company's revenue of MYR 13,503,000 is relatively flat compared to historical data, and there is no indication of a clear upward trend. The negative operating and free cash flows suggest that the company may need to rely on external financing or asset sales to fund its operations and capital expenditures, which could impact its long-term growth potential.
The risk assessment for Adventa Bhd highlights a medium liquidity risk, primarily due to the company's negative net cash position after accounting for total debt. While the company's debt-to-equity ratio is low at 0.01, indicating minimal leverage, the negative cash flows and capital expenditures raise concerns about its ability to maintain liquidity without external financing. The risk of dilution is currently low, as there is no evidence of recent share issuance or plans for future dilution.
No recent filings or transcripts are available in the provided data to indicate any material events or strategic shifts at Adventa Bhd. The company's financial performance and risk profile remain largely unchanged from the latest available data.
- Adventa Bhd has a strong current ratio of 5.6, but negative operating and free cash flows raise concerns about liquidity sustainability.
- The company's ROE and ROA are below typical industry benchmarks, indicating limited profitability.
- Revenue is concentrated in a single business segment and geographic market, increasing operational risk.
- Growth appears to be constrained by flat revenue and negative cash flows, with no clear upward trajectory.
- Liquidity risk is moderate, and dilution risk is currently low.
Bull / Bear case
Generated · model-assistedAdventa carries minimal leverage with a debt-to-equity ratio of 0.01, well below the 0.20 median.
The firm faces low dilution risk and low credit risk according to current risk assessments.
Return on equity of 0.33% lags significantly behind the 1.42% cohort median.
Cash conversion of -20.39% places the company in the bottom quartile of its peer group.
In focus — financials by report
Revenue MYR 14.0M, −17,6% YoY; Operating income −428,6% YoY.
- ▍Revenue MYR 14.0M, −17,6% YoY
- ▍Operating income −428,6% YoY
- ▍Net income −824,6% YoY
- ▍Free cash flow −722,4% YoY
- ▍Net margin -45.5%
Revenue MYR 11.8M, −23,7% YoY; Operating income −75,2% YoY.
- ▍Revenue MYR 11.8M, −23,7% YoY
- ▍Operating income −75,2% YoY
- ▍Net income −74,1% YoY
- ▍Free cash flow +113,8% YoY
- ▍Net margin 1.5%
Revenue MYR 13.9M, +12,9% YoY; Operating income +53,7% YoY.
- ▍Revenue MYR 13.9M, +12,9% YoY
- ▍Operating income +53,7% YoY
- ▍Net income +28,1% YoY
- ▍Free cash flow +103,4% YoY
- ▍Net margin 3.1%
Revenue MYR 13.6M, +0,5% YoY; Operating income −21,9% YoY.
- ▍Revenue MYR 13.6M, +0,5% YoY
- ▍Operating income −21,9% YoY
- ▍Net income +3,0% YoY
- ▍Free cash flow −28,3% YoY
- ▍Net margin 2.3%
Revenue MYR 17.0M; Operating income MYR 1.4M.
- ▍Revenue MYR 17.0M
- ▍Operating income MYR 1.4M
- ▍Net margin 5.2%
Revenue MYR 15.4M; Operating income MYR 1.3M.
- ▍Revenue MYR 15.4M
- ▍Operating income MYR 1.3M
- ▍Net margin 4.3%
Revenue MYR 58.3M, +56,3% YoY; Operating income +142,5% YoY.
- ▍Revenue MYR 58.3M, +56,3% YoY
- ▍Operating income +142,5% YoY
- ▍Net income +124,1% YoY
- ▍Free cash flow +15,2% YoY
- ▍Net margin 3.8%
Revenue MYR 37.3M, −36,8% YoY; Operating income −109,8% YoY.
- ▍Revenue MYR 37.3M, −36,8% YoY
- ▍Operating income −109,8% YoY
- ▍Net income −76,5% YoY
- ▍Free cash flow −501,7% YoY
- ▍Net margin -24.3%
Revenue MYR 59.0M, −39,5% YoY; Operating income −157,0% YoY.
- ▍Revenue MYR 59.0M, −39,5% YoY
- ▍Operating income −157,0% YoY
- ▍Net income −139,2% YoY
- ▍Free cash flow −151,2% YoY
- ▍Net margin -8.7%
Valuation TTM
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Adventa Bhd Market data — financials · 2026-05-27